Hand Function in Patients With Poly- or Dermatomyositis
NCT ID: NCT00866125
Last Updated: 2009-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
31 participants
OBSERVATIONAL
2002-04-30
2002-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is a cross-sectional study. To assess hand function the investigators will measure grip force with Grippit and arm/hand mobility using EPM-ROM scale. The activity performance will be measured with Myositis Activities Profile and health related quality of life will be assessed with SF-36.
The investigators' hypothesis is that hand function is reduced in comparison to the healthy population and that hand function affects both activity performance and health related quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Affecting Hand Dysfunction in Patient With Rheumatoid Arthritis and Its Correlation With Quality of Life
NCT03274570
Relationship Between Grip Endurance, Disability of Upper Extremity and Quality of Life in Patients With RA
NCT04563455
The Impact of Thumb Carpometacarpal Osteoarthritis on General Health
NCT01133197
The Effect of Psoriatic Arthritis on the Functions of the Hand
NCT04540809
Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients
NCT04378621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rheumatology unit, Department of Medicine.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ingrid E Lundberg, MD, PhD
Role: STUDY_DIRECTOR
Karolinska Institutet
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.